BMS Archive

Plant · Scientific monograph

Foeniculum vulgare

Fennel

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Digestive traditional use, Menstrual symptom research

Research overview

Historical use

EMA's monograph supports traditional-use claims only for specified sweet-fennel fruit preparations and indications; it does not cover all fennel varieties or parts [1].

Modern research context

A systematic review pooled trials of fennel for primary dysmenorrhea, but products and preparations varied [2]. The pooled result cannot be attributed to the specific sweet-fennel fruit preparations covered by EMA without full-text product-level comparison [1,2].

Adverse effects

EMA flags estragole exposure and limited safety data for some groups and preparations; trial-level adverse-event reporting requires full-text review [1,2].

Contraindications

Keep sweet fennel fruit, other varieties, essential oil and food use distinct. EMA limits age and use conditions for medicinal products; follow its product-specific precautions [1].

Clinical and phytochemical data

Used part

EMA scope: fruit of Foeniculum vulgare subsp. vulgare var. dulce; clinical trials in the review used varied fennel products [1,2].

Primary active compounds

  • Anethole and estragole are constituents in fennel fruit preparations; amounts vary by variety and product [1].

Mechanism of action

Clinical outcomes in the dysmenorrhea review do not establish a validated mechanism [2].

Pharmacokinetics

Absorption

No general human PK profile for fennel fruit medicines was identified in the cited clinical synthesis [1,2].

Distribution

Not characterized.

Metabolism

Not characterized.

Excretion

Not characterized.

Safety and interactions

Drug interactions

No generalized clinical interaction profile established for fennel preparations.

Toxicity

Risk assessment must be preparation-specific; EMA discusses estragole exposure and the need to limit exposure [1].

Special precautions

Pregnancy

Pregnancy data for medicinal preparations are limited; follow the EMA monograph and product-specific restrictions [1].

Lactation

Lactation data are limited; no generalized medicinal-use safety claim is established [1].

Hepatic impairment

No hepatic-impairment data identified.

Renal impairment

No renal-impairment data identified.

Sources and references

  1. [1] EMA/HMPC. European Union herbal monograph on Foeniculum vulgare Miller subsp. vulgare var. dulce (Mill.) Batt. & Trab., fructus. EMA/HMPC/372841/2016, revision 1.
  2. [2] Hadis Shahrahmani et al. Effect of fennel on primary dysmenorrhea: a systematic review and meta-analysis. Journal of Complementary and Integrative Medicine. 2021;18(2):261–269. PMID: 34187122. DOI: 10.1515/jcim-2019-0212.

Additional source links

Continue browsing